Favipiravir
Favipiravir is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target polymerase PB1.
| Trade Name | |
|---|---|
| Common Name | Favipiravir |
| ChEMBL ID | CHEMBL221722 |
| Indication | |
| Drug Class | Antivirals |
